Found 8 matching trials
Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS) PHASE2 The primary objective of Part 1 of this study is to evaluate the effects of...
Show More Learn More & Join Trial
BIIB033 In Acute Optic Neuritis (AON) PHASE2 The primary objective of the study is to evaluate the efficacy of BIIB033 i...
Show More Learn More & Join Trial
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex PHASE2 The primary objective of the study is to evaluate the efficacy of BIIB033 i...
Show More Location
North Central Neurology Assoc PC
Learn More & Join Trial
Safety Study of BIIB033 in Subjects With Multiple Sclerosis PHASE1 The main purpose of the study is to evaluate the safety, tolerability, and ...
Show More Learn More & Join Trial
BIIB033 Single Ascending Dose Study in Healthy Volunteer Subjects PHASE1 The primary objective of the study is to evaluate the safety and tolerabili...
Show More Learn More & Join Trial
Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BIIB033 in Healthy Japanese Participants PHASE1 The primary objective of this study is to assess the safety and tolerabilit...
Show More Learn More & Join Trial
Pharmacokinetics, Safety and Tolerability of Single Doses of BIIB033 (Opicinumab) Produced by 2 Manufacturing Processes PHASE1 The primary objective of the study is to characterize the pharmacokinetics ...
Show More Learn More & Join Trial
Long-Term Assessment of Remyelinating Therapy PHASE2 The primary objective of the study is to assess full-field visual evoked po...
Show More Learn More & Join Trial